About
Technology
Issues
FAQ
Links
Official Page
Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor‐bearing microparticles: a randomized‐controlled phase II trial (the Microtec study)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.